Inventor
SHEPARD STACEY
US59 patents
⚠️ This page may combine multiple inventors who share the name “SHEPARD STACEY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INCYTE CORP
38 patentsUS9079912B2Jul 14, 2015
Heteroaryl substituted pyrrolo[2,3-B] pyridines and pyrrolo[2,3-B] pyrimidines as Janus kinase inhibitors
INCYTE CORP75 citations99
US7598257B2Oct 6, 2009
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
INCYTE CORP328 citations99
US10639310B2May 5, 2020
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
INCYTE CORP20 citations98
US10398699B2Sep 3, 2019
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
INCYTE CORP31 citations98
US9974790B2May 22, 2018
Heteroaryl substituted pyrrolo[2,3-B] pyridines and pyrrolo[2,3-B] pyrimidines as janus kinase inhibitors
INCYTE CORP40 citations98
US9662335B2May 30, 2017
Heteroaryl substituted pyrrolo[2,3-B] pyridines and pyrrolo[2,3-B] pyrimidines as janus kinase inhibitors
INCYTE CORP25 citations98
US9206187B2Dec 8, 2015
Heteroaryl substituted pyrrolo[2,3-B] pyridines and pyrrolo[2,3-B] pyrimidines as Janus kinase
INCYTE CORP55 citations98
US8933086B2Jan 13, 2015
Heteroaryl substituted pyrrolo[2,3-B]pyridines and pyrrolo[2,3-B]pyrimidines as Janus kinase inhibitors
INCYTE CORP71 citations98
US9334274B2May 10, 2016
N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
INCYTE CORP57 citations97
US7834022B2Nov 16, 2010
Metabolites of the Janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
INCYTE CORP141 citations95
US11331320B2May 17, 2022
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
INCYTE CORP12 citations94
US10640506B2May 5, 2020
Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidines derivatives as JAK inhibitors
INCYTE CORP19 citations94
US10442803B2Oct 15, 2019
Tricyclic heterocycles as bet protein inhibitors
INCYTE CORP17 citations94
US10138248B2Nov 27, 2018
Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines, substituted imidazo[1,2-b]pyridazines and substituted imidazo[1,2-a]pyrazines as PI3K-γ inhibitors
INCYTE CORP36 citations94
US9777003B2Oct 3, 2017
Tricyclic heterocycles as bet protein inhibitors
INCYTE CORP25 citations94
US9309246B2Apr 12, 2016
Tricyclic heterocycles as BET protein inhibitors
INCYTE CORP33 citations94
US9193733B2Nov 24, 2015
Piperidinylcyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors
INCYTE CORP33 citations94
US9814722B2Nov 14, 2017
Heteroaryl substituted pyrrolo[2,3-B] pyridines and pyrrolo[2,3-B] pyrimidines as janus kinase inhibitors
INCYTE CORP13 citations93
US10065963B2Sep 4, 2018
Heterocyclic compounds as PI3K-γ inhibitors
INCYTE CORP16 citations92
US11091484B2Aug 17, 2021
Tricyclic heterocycles as BET protein inhibitors
INCYTE CORP8 citations84
US10975088B2Apr 13, 2021
Imidazo[2,1-f][1,2,4]triazine compounds as pi3k-y inhibitors
INCYTE CORP6 citations84
US10738057B2Aug 11, 2020
Tertiary alcohols as PI3K-γ inhibitors
INCYTE CORP5 citations84
US10479795B2Nov 19, 2019
Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines and substituted imidazo[1,2-b]pyridazines as PI3K-gamma inhibitors
INCYTE CORP13 citations84
US10472368B2Nov 12, 2019
Heterocyclic compounds as PI3K-γ inhibitors
INCYTE CORP12 citations84
US10463667B2Nov 5, 2019
Metabolites of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
INCYTE CORP5 citations83
US9512161B2Dec 6, 2016
Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7H-pyrrolo[2,3-D]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
INCYTE CORP9 citations82
US11926630B2Mar 12, 2024
Tertiary alcohols as PI3K-γ inhibitors
INCYTE CORP2 citations73
US11926616B2Mar 12, 2024
Aminopyrazine diol compounds as PI3K-γ inhibitors
INCYTE CORP2 citations73
US11744832B2Sep 5, 2023
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
INCYTE CORP0 citations73
US11352340B2Jun 7, 2022
Pyridine and pyridimine compounds as PI3K-gamma inhibitors
INCYTE CORP3 citations73
US11225486B2Jan 18, 2022
Tertiary alcohols as PI3K-γ inhibitors
INCYTE CORP4 citations73
US11091491B2Aug 17, 2021
Heterocyclic compounds as PI3K-y inhibitors
INCYTE CORP4 citations73
US10669262B2Jun 2, 2020
Aminopyrazine diol compounds as PI3K-γ inhibitors
INCYTE CORP4 citations73
US11161838B2Nov 2, 2021
Heterocyclic derivatives as PI3K inhibitors
INCYTE CORP4 citations72
US11078204B2Aug 3, 2021
Heterocyclic derivatives as PI3K inhibitors
INCYTE CORP2 citations72
US11046658B2Jun 29, 2021
Aminopyrazine derivatives as PI3K-γ inhibitors
INCYTE CORP4 citations72
US11691971B2Jul 4, 2023
Naphthyridinone compounds as JAK2 V617F inhibitors
INCYTE CORP1 citations63
US11396502B2Jul 26, 2022
Substituted heterocyclic derivatives as PI3K inhibitors
INCYTE CORP1 citations63
RODGERS JAMES D
12 patentsUS8530485B2Sep 10, 2013
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
RODGERS JAMES D98 citations99
US8158616B2Apr 17, 2012
Azetidine and cyclobutane derivatives as JAK inhibitors
RODGERS JAMES D170 citations99
US8946245B2Feb 3, 2015
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
RODGERS JAMES D70 citations98
US8933085B2Jan 13, 2015
Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors
RODGERS JAMES D96 citations98
US8541425B2Sep 24, 2013
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
RODGERS JAMES D92 citations98
US8420629B2Apr 16, 2013
Azetidine and cyclobutane derivatives as JAK inhibitors
RODGERS JAMES D105 citations98
US8415362B2Apr 9, 2013
Pyrazolyl substituted pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
RODGERS JAMES D117 citations98
US8889697B2Nov 18, 2014
Metabolites of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
RODGERS JAMES D79 citations97
US8716303B2May 6, 2014
N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
RODGERS JAMES D109 citations97
US8486902B2Jul 16, 2013
Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7H-pyrrolo[2,3-d] pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
RODGERS JAMES D125 citations97
US8748401B2Jun 10, 2014
Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7H pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
RODGERS JAMES D80 citations96
US9249145B2Feb 2, 2016
Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
RODGERS JAMES D45 citations94
Showing the top 50 of 59 patents by PatentIndex Score.